Clinical Trial Update: The Use of HEMOBAG to Salvage Blood After Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HEMOBAG to salvage blood after cardiac surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• HEMOBAG

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Cardiopulmonary Bypass, Cardiac Diseases | Phase 2 | Status: TERMINATED